| Description |
1 online resource (v, 168 pages) : color illustrations, color maps |
| Contents |
""Book Cover""; ""Title""; ""Copyright""; ""Contents""; ""Introduction""; ""I Hepatitis C""; ""1. Natural History of Hepatitis C: Epidemiology""; ""2. Natural History of Hepatitis C: Hepatic Manifestations""; ""3. Natural of Hepatitis C: Extrahepatic Manifestations and Quality of Life""; ""4. Management Protocols in Chronic Hepatitis C""; ""5. Management of Relapsers and Nonresponders�Maintenance Therapy""; ""6. Management of Patients with Cirrhosis""; ""7. Management of Patients Coinfected by HCV and HIV""; ""8. Management of HCV Infection After Liver Transplantation"" |
|
""9. Management of Patients with Renal Disease""""10. Other Difficult-to-treat Populations""; ""11. Safety of Interferon, Pegylated Interferon (PEG-IFN) and Ribavirin""; ""12. Who Needs to be Treated and How to Explain the Goals to the Patient""; ""13. What is the Cost-effectiveness of Combination Regiments?""; ""14. Management of Acute Hepatitis C""; ""15. Practical Guidelines for the Management of Hepatitis C""; ""16. New Drugs in Development""; ""References""; ""II Hepatitis B""; ""17. Natural History of Hepatitis B: Epidemiology"" |
|
""18. Natural History of Hepatitis B: Hepatic Manifestations""""19. Natural History of Hepatitis B: Extrahepatic Manifestations and Quality of Life""; ""20. Goal of Treatment in Chronic Hepatitis B""; ""21. Efficacy of Interferon and Pegylated Interferon (PEG-IFN)""; ""22. Efficacy of Lamivudine""; ""23. Comparison Between Lamivudine, Interferon and the Combination of Interferon and Lamivudine""; ""24. Safety of Lamivudine""; ""25. Efficacy of Adefovir""; ""26. Safety of Adefovir""; ""27. First-line Treatment of Chronic Hepatitis B: Adefovir, Lamivudine or Interferon?"" |
|
""28. New Drugs in Development""""29. Who Needs to be Treated and How to Explain the Goals to the Patient""; ""30. Management of Relapsers and Nonresponders""; ""31. Management of Patients Coinfected by HBV and HIV""; ""32. Management of Transplanted Patients Chronically Infected by HBV""; ""33. Cost-effectiveness of Treatment""; ""References""; ""III Biochemical Markers: An Alternative to Liver Biopsies""; ""34. Needle Biopsy of the Liver: Value and Limitations""; ""35. Advantage and Limits of Biochemical Markers""; ""References"" |
| Summary |
Provides a practical explanation of the natural history and management of the diseases, and examines the benefits of the most recent drugs, and their effects, whether used in isolation or as part of a combination therapy. This second edition expands the coverage of biochemical markers and of the tgreatment of various difficult-to-treat patients |
| Notes |
"A Martin Dunitz book." |
|
Previous ed. published as: Hepatitis C infection. London : Martin Dunitz, 2000 |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Print version record |
| Subject |
Hepatitis B -- Treatment
|
|
Hepatitis C -- Treatment
|
|
Interferon -- Therapeutic use
|
|
Biochemical markers -- Therapeutic use
|
|
Hepatitis, Viral.
|
|
Hepatitis B, Chronic -- drug therapy
|
|
Hepatitis C, Chronic -- drug therapy
|
|
Hepatitis B, Chronic -- complications
|
|
Hepatitis C, Chronic -- complications
|
|
FOREIGN LANGUAGE STUDY -- Spanish.
|
|
Hepatitis, Viral
|
|
Hepatitis C -- Treatment
|
|
Interferon -- Therapeutic use
|
| Form |
Electronic book
|
| Author |
Poynard, T. (Thierry).
Hepatitis C infection
|
| ISBN |
0203357183 |
|
9780203357187 |
|
